Valeant Pharma (VRX) sued in New York Federal court over alleged overcharges - Reuters
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
(Updated - August 29, 2016 2:01 PM EDT)
Valeant Pharma (NYSE: VRX) was sued in New York Federal court over alleged overcharges, according to Reuters. The lawsuit was brought on behalf of so-called third party payors over alleged overcharges from January 2013 to October 2015.
Plaintiffs include New York hotel trade group's health benefits fund, and detectives endowment association of New York City, the report noted.
The lawsuit accuses Valeant of violating U.S. racketeer influenced and corrupt organizations act, or RICO, and seeks class action status, unspecified compensatory and triple damages.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Valeant Pharma (VRX) Moves Off Lows on Bill Miller Comments
- Inovio Pharma (INO) Announces FDA Clinical Hold Placed on Proposed VGX-3100 Phase 3
- Valeant Pharma (VRX)
Create E-mail Alert Related CategoriesLitigation, Short Sales, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!